目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Application
1.2.3. Dosage Form
1.2.4. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Inhalable Biologics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.4. Pipeline Analysis
3.4.1. List of Drug Candidates (Phase 1 to Phase 3)
3.4.2. Potential Drugs to be Commercialized in the Forecast Period
3.4.3. Phase 3 Drug Forecast
3.5. Case Study Analysis

Chapter 4. Inhalable Biologics Market: Type Business Analysis
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Peptides and Proteins
4.4.1. Peptides and Proteins Market, 2018 - 2030 (USD Million)
4.5. Vaccines
4.5.1. Vaccines Market, 2018 - 2030 (USD Million)
4.6. Monoclonal Antibodies
4.6.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Million)
4.7. RNAi-based Therapeutics
4.7.1. RNAi-based Therapeutics Market, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Other Type Market, 2018 - 2030 (USD Million)

Chapter 5. Inhalable Biologics Market: Application Business Analysis
5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Respiratory Diseases
5.4.1. Respiratory Diseases Market, 2018 - 2030 (USD Million)
5.4.2. COPD
5.4.2.1. COPD Market, 2018 - 2030 (USD Million)
5.4.3. Asthma
5.4.3.1. Asthma Market, 2018 - 2030 (USD Million)
5.4.4. Cystic Forbis
5.4.4.1. Cystic Forbis Market, 2018 - 2030 (USD Million)
5.4.5. Covid-19
5.4.5.1. Covid-19 Market, 2018 - 2030 (USD Million)
5.4.6. Others
5.4.6.1. Others Market, 2018 - 2030 (USD Million)
5.5. Diabetes
5.5.1. Diabetes Market, 2018 - 2030 (USD Million)
5.6. Cancer
5.6.1. Cancer Market, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Inhalable Biologics Market: Dosage Form Business Analysis
6.1. Dosage Form Market Share, 2024 & 2030
6.2. Dosage Form Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2018 to 2030 (USD Million)
6.4. Dry Powder Inhalers
6.4.1. Dry Powder Inhalers Market, 2018 - 2030 (USD Million)
6.5. Metered Dose Inhalers
6.5.1. Metered Dose Inhalers Market, 2018 - 2030 (USD Million)
6.6. Nebulizers
6.6.1. Nebulizers Market, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Inhalable Biologics Market: Dosage Form Business Analysis
7.1. Dosage Form Market Share, 2024 & 2030
7.2. Dosage Form Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2018 to 2030 (USD Million)
7.4. Hospital Pharmacies
7.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
7.5. Retail Pharmacies
7.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
7.6. Online Pharmacies
7.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 8. Inhalable Biologics Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. North America Inhalable Biologics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Target Disease Prevalence
8.4.2.3. Regulatory Framework
8.4.2.4. Reimbursement Framework
8.4.2.5. U.S. Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Regulatory Framework
8.4.3.4. Reimbursement Framework
8.4.3.5. U.S. Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Regulatory Framework
8.4.4.4. Reimbursement Framework
8.4.4.5. Mexico Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement Framework
8.5.2.5. UK Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement Framework
8.5.3.5. Germany Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Regulatory Framework
8.5.4.4. Reimbursement Framework
8.5.4.5. France Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Target Disease Prevalence
8.5.5.3. Regulatory Framework
8.5.5.4. Reimbursement Framework
8.5.5.5. Italy Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Target Disease Prevalence
8.5.6.3. Regulatory Framework
8.5.6.4. Reimbursement Framework
8.5.6.5. Spain Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Target Disease Prevalence
8.5.7.3. Regulatory Framework
8.5.7.4. Reimbursement Framework
8.5.7.5. Denmark Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Target Disease Prevalence
8.5.8.3. Regulatory Framework
8.5.8.4. Reimbursement Framework
8.5.8.5. Sweden Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Target Disease Prevalence
8.5.9.3. Regulatory Framework
8.5.9.4. Reimbursement Framework
8.5.9.5. Norway Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Target Disease Prevalence
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement Framework
8.6.2.5. Japan Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement Framework
8.6.3.5. China Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement Framework
8.6.4.5. India Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement Framework
8.6.5.5. Australia Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Target Disease Prevalence
8.6.6.3. Regulatory Framework
8.6.6.4. Reimbursement Framework
8.6.6.5. South Korea Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Target Disease Prevalence
8.6.7.3. Regulatory Framework
8.6.7.4. Reimbursement Framework
8.6.7.5. Thailand Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Target Disease Prevalence
8.7.2.3. Regulatory Framework
8.7.2.4. Reimbursement Framework
8.7.2.5. Brazil Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Target Disease Prevalence
8.7.3.3. Regulatory Framework
8.7.3.4. Reimbursement Framework
8.7.3.5. Argentina Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Middle East and Africa
8.8.1. Middle East and Africa Inhalable Biologics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Target Disease Prevalence
8.8.2.3. Regulatory Framework
8.8.2.4. Reimbursement Framework
8.8.2.5. South Africa Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Target Disease Prevalence
8.8.3.3. Regulatory Framework
8.8.3.4. Reimbursement Framework
8.8.3.5. Saudi Arabia Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Target Disease Prevalence
8.8.4.3. Regulatory Framework
8.8.4.4. Reimbursement Framework
8.8.4.5. UAE Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Target Disease Prevalence
8.8.5.3. Regulatory Framework
8.8.5.4. Reimbursement Framework
8.8.5.5. Kuwait Inhalable Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. Kamada Pharmaceuticals
9.5.1.1. Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. MannKind Corporation
9.5.2.1. Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. Ab Initio Pharma
9.5.3.1. Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. Ocugen, Inc.
9.5.4.1. Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. CanSino Biologics
9.5.5.1. Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. AstraZeneca
9.5.6.1. Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global inhalable biologics market, by region, 2018 - 2030 (USD Million)
Table 4 Global inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 5 Global inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 6 Global inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 7 Global inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 8 North America inhalable biologics market, by country, 2018 - 2030 (USD Million)
Table 9 North America inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 10 North America inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 11 North America inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 12 North America inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 13 U.S. inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 14 U.S. Inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 16 U.S. inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 17 Canada inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 18 Canada inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 19 Canada inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 20 Canada inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 21 Mexico inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 22 Mexico inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 23 Mexico inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 24 Mexico inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 25 Europe inhalable biologics market, by country, 2018 - 2030 (USD Million)
Table 26 Europe inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 27 Europe inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 28 Europe inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 29 Europe inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 30 UK inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 31 UK Inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 32 UK inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 33 UK inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 34 Germany inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 35 Germany inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 36 Germany inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 37 Germany inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 38 France inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 39 France Inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 40 France inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 41 France inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 42 Italy inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 43 Italy inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 44 Italy inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 45 Italy inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 46 Spain inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 47 Spain inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 48 Spain inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 49 Spain inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 50 Norway inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 51 Norway Inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 52 Norway inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 53 Norway inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 54 Denmark inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 55 Denmark inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 56 Denmark inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 57 Denmark inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 58 Sweden inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 59 Sweden inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 60 Sweden inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 61 Sweden inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 62 Asia Pacific inhalable biologics market, by country, 2018 - 2030 (USD Million)
Table 63 Asia Pacific inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 64 Asia Pacific inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 65 Asia Pacific inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 66 Asia Pacific inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 67 Japan inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 68 Japan inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 69 Japan inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 70 Japan inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 71 China inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 72 China inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 73 China inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 74 China inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 75 India inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 76 India inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 77 India inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 78 India inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 79 Australia inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 80 Australia inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 81 Australia inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 82 Australia inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 83 South Korea inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 84 South Korea inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 85 South Korea inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 86 South Korea inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 87 Thailand inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 88 Thailand inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 89 Thailand inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 90 Thailand inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 91 Latin America inhalable biologics market, by country, 2018 - 2030 (USD Million)
Table 92 Latin America inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 93 Latin America inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 94 Latin America inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 95 Latin America inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 96 Brazil inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 97 Brazil inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 98 Brazil inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 99 Brazil inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 100 Argentina inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 101 Argentina inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 103 Argentina inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Inhalable biologics market, by country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 109 South Africa inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 110 South Africa inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 112 South Africa inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 117 UAE inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 118 UAE inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 119 UAE inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 120 UAE inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)
Table 121 Kuwait inhalable biologics market, by type, 2018 - 2030 (USD Million)
Table 122 Kuwait inhalable biologics market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait inhalable biologics market, by dosage form, 2018 - 2030 (USD Million)
Table 124 Kuwait inhalable biologics market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Inhalable biologics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and application outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Inhalable biologics market dynamics
Fig. 12 Inhalable biologics market: Porter’s five forces analysis
Fig. 13 Inhalable biologics market: PESTLE analysis
Fig. 14 Biologic market, 2018 - 2030 (USD Million)
Fig. 15 Peptides and Proteins market, 2018 - 2030 (USD Million)
Fig. 16 Vaccines market, 2018 - 2030 (USD Million)
Fig. 17 Monoclonal Antibodies market, 2018 - 2030 (USD Million)
Fig. 18 RNAi-based Therapeutics market, 2018 - 2030 (USD Million)
Fig. 19 Others market, 2018 - 2030 (USD Million)
Fig. 20 Applicationmarket, 2018 - 2030 (USD Million)
Fig. 21 Respiratory diseases market, 2018 - 2030 (USD Million)
Fig. 22 COPD market, 2018 - 2030 (USD Million)
Fig. 23 Asthma market, 2018 - 2030 (USD Million)
Fig. 24 Cystic Forbis market, 2018 - 2030 (USD Million)
Fig. 25 Covid-19 market, 2018 - 2030 (USD Million)
Fig. 26 Others market, 2018 - 2030 (USD Million)
Fig. 27 Diabetes market, 2018 - 2030 (USD Million)
Fig. 28 Cancer market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Dosage Form market, 2018 - 2030 (USD Million)
Fig. 31 Dry Powder Inhalers market, 2018 - 2030 (USD Million)
Fig. 32 Metered Dose Inhalers market, 2018 - 2030 (USD Million)
Fig. 33 Nebulizers market, 2018 - 2030 (USD Million)
Fig. 34 Others market, 2018 - 2030 (USD Million)
Fig. 35 Distribution Channel market, 2018 - 2030 (USD Million)
Fig. 36 Hospital Pharmacies market, 2018 - 2030 (USD Million)
Fig. 37 Retail Pharmacies market, 2018 - 2030 (USD Million)
Fig. 38 Online Pharmacies market, 2018 - 2030 (USD Million)
Fig. 39 Inhalable biologics market revenue, by region
Fig. 40 Regional marketplace: Key takeaways
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 North America inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 43 U.S. country dynamics
Fig. 44 U.S. inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 45 Canada country dynamics
Fig. 46 Canada inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 47 Mexico country dynamics
Fig. 48 Mexico inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 49 Europe inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 50 UK country dynamics
Fig. 51 UK inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 52 Germany country dynamics
Fig. 53 Germany inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 54 France country dynamics
Fig. 55 France inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 56 Italy country dynamics
Fig. 57 Italy inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 58 Spain country dynamics
Fig. 59 Spain inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 60 Norway country dynamics
Fig. 61 Norway inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 62 Sweden country dynamics
Fig. 63 Sweden inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 64 Denmark country dynamics
Fig. 65 Denmark inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 66 Asia Pacific inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 67 Japan country dynamics
Fig. 68 Japan inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 69 China country dynamics
Fig. 70 China inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 71 India country dynamics
Fig. 72 India inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 73 Australia country dynamics
Fig. 74 Australia inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 75 South Korea country dynamics
Fig. 76 South Korea inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 77 Thailand country dynamics
Fig. 78 Thailand inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 79 Latin America inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 80 Brazil country dynamics
Fig. 81 Brazil inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 82 Argentina country dynamics
Fig. 83 Argentina inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 84 MEA inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 85 South Africa country dynamics
Fig. 86 South Africa inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 87 Saudi Arabia country dynamics
Fig. 88 Saudi Arabia inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 89 UAE country dynamics
Fig. 90 UAE inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 91 Kuwait country dynamics
Fig. 92 Kuwait inhalable biologics market, 2018 - 2030 (USD Million)
Fig. 93 Company categorization
Fig. 94 Company market position analysis
Fig. 95 Strategic framework